[TimAlerts] Some earnings before Tuesday’s open $ABG AGR $AKS $ASTE $ATI $AXE $BAX $BHI $BPOP $CAT $CIT $CNC $CPLA CTG $CVLT $CYNO $DD $EAT $EDU $ETR $FBC $FBP FCAU $FCX $FELE $GBX $GLW $GM $GPK HUBB $IIVI $JBLU $JNS $KEY $KKR $LLY $LMT LPT $MAS $MDSO $MINI $MMC $MMM $MRK $NCI $NLSN $NVS $PCAR $PG $PII $PNR $R $RTIX $S $SAVE $SCHN $SERV $SHW $SIR $ST STAY $TNC $UA $USG $UTX $VLO $WAB $WAT $WDR $WHR $WSO

[TimAlerts] Scalp Ideas @ScalpIdeas $ANAC JMP is saying $NVS could bid, that much is true. Separately they value $ANAC @ $130 tgt. down from $175. Two different things.

[TimAlerts] Scalp Ideas @ScalpIdeas $ANAC there is fabricated hype out there that Jmp Securities is saying $130 bid from $NVS coming. NOT TRUE.

[TimAlerts] $NVS not NVT ..

[TimAlerts] $XOMA Sitting on $69MILL in cash with a estimated $480MILL in potential $NVS revenue - Worth at least $6 PPS

[TimChallenge] No there is no news that is linking them together. GKOPENA is saying that there is rumors that $NVS is acquiring $PBMD

[TimChallenge] If $PBMD only spiked on to $2 on the news with $NVS and fell back down, then I am not sure how much this new news will impact it when it does not directly involve them...whats the source for the new info (I don't see it thats why I was asking

[TimChallenge] $NVS and $AMGN just made a deal to work together on their alzheimers drug. $NVS made a deal with $PBMD back in Aug 14th. Idk what to do

[TimAlerts] novartis $NVS is a multi billion dollar company with stock over $100/share that purchased $PBMD drug... does that type of news warrant a hold over the weekend and multi day run? PM ME

[TimAlerts] $PBMD $NVS Prima BioMed announces commencement of milestones for IMP701 program Prima BioMed (PBMD) announced it will receive an undisclosed clinical milestone payment from its collaboration and licensing agreement with Novartis (NVS) relating to its Phase I IMP701 LAG-3 antibody. The antibody is being trialled for the treatment of cancer. Immutep and CoStim Pharmaceuticals entered into a commercial licensing and collaboration agreement in September 2012, under which CoStim obtained a licence to